Trial Outcomes & Findings for Clinical Evaluation of a Manufacturing Process for a Frequent Replacement Silicone Hydrogel Multifocal Contact Lens (NCT NCT05765227)
NCT ID: NCT05765227
Last Updated: 2024-04-16
Results Overview
VA was assessed binocularly (both eyes together) using a letter chart and measured in logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with lower logMAR values indicating better visual acuity. No hypothesis testing was prespecified for this endpoint.
COMPLETED
NA
18 participants
Day 2, each study lens type worn during the corresponding crossover period
2024-04-16
Participant Flow
Participants were recruited from 1 investigative site located in 1 country (US).
Of the 18 enrolled, 1 participant was exited prior to study start as a screen failure. This reporting group includes all participants exposed to any study lenses evaluated in this study (17).
Participant milestones
| Measure |
LID#224381, Then AOHG MF
Lehfilcon A multifocal contact lenses worn first, with lotrafilcon B multifocal contact lenses worn second in pre-determined order. Each study lens type was worn bilaterally (in both eyes) for approximately 2 days in a daily wear modality. CLEAR CARE was used for nightly cleaning and disinfection.
|
AOHG MF, Then LID#224381
Lotrafilcon B multifocal contact lenses worn first, with lehfilcon A multifocal contact lenses worn second in pre-determined order. Each study lens type was worn bilaterally (in both eyes) for approximately 2 days in a daily wear modality. CLEAR CARE was used for nightly cleaning and disinfection.
|
|---|---|---|
|
First Wear Period (Approx. 2 Days)
STARTED
|
8
|
9
|
|
First Wear Period (Approx. 2 Days)
COMPLETED
|
8
|
9
|
|
First Wear Period (Approx. 2 Days)
NOT COMPLETED
|
0
|
0
|
|
Second Wear Period (Approx. 2 Days)
STARTED
|
8
|
9
|
|
Second Wear Period (Approx. 2 Days)
COMPLETED
|
8
|
9
|
|
Second Wear Period (Approx. 2 Days)
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Clinical Evaluation of a Manufacturing Process for a Frequent Replacement Silicone Hydrogel Multifocal Contact Lens
Baseline characteristics by cohort
| Measure |
LID#224381, Then AOHG MF
n=8 Participants
Lehfilcon A multifocal contact lenses worn first, with lotrafilcon B multifocal contact lenses worn second in pre-determined order. Each study lens type was worn bilaterally (in both eyes) for approximately 2 days in a daily wear modality. CLEAR CARE was used for nightly cleaning and disinfection.
|
AOHG MF, Then LID#224381
n=9 Participants
Lotrafilcon B multifocal contact lenses worn first, with lehfilcon A multifocal contact lenses worn second in pre-determined order. Each study lens type was worn bilaterally (in both eyes) for approximately 2 days in a daily wear modality. CLEAR CARE was used for nightly cleaning and disinfection.
|
Total
n=17 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
64.1 years
STANDARD_DEVIATION 4.3 • n=99 Participants
|
62.4 years
STANDARD_DEVIATION 5.2 • n=107 Participants
|
63.2 years
STANDARD_DEVIATION 4.7 • n=206 Participants
|
|
Sex: Female, Male
Female
|
3 Participants
n=99 Participants
|
1 Participants
n=107 Participants
|
4 Participants
n=206 Participants
|
|
Sex: Female, Male
Male
|
5 Participants
n=99 Participants
|
8 Participants
n=107 Participants
|
13 Participants
n=206 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
8 Participants
n=99 Participants
|
9 Participants
n=107 Participants
|
17 Participants
n=206 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
White
|
7 Participants
n=99 Participants
|
7 Participants
n=107 Participants
|
14 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
Black or African American
|
1 Participants
n=99 Participants
|
2 Participants
n=107 Participants
|
3 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
American Indian or Alaska Native
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
Asian
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
Other
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
PRIMARY outcome
Timeframe: Day 2, each study lens type worn during the corresponding crossover periodPopulation: This analysis population includes all subjects/eyes exposed to any study lenses evaluated in this study.
VA was assessed binocularly (both eyes together) using a letter chart and measured in logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with lower logMAR values indicating better visual acuity. No hypothesis testing was prespecified for this endpoint.
Outcome measures
| Measure |
LID#224381
n=17 Participants
Lehfilcon A multifocal contact lenses worn during first wear period or second wear period, as pre-determined.
|
AOHG MF
n=17 Participants
Lotrafilcon B multifocal contact lenses worn during first wear period or second wear period, as pre-determined.
|
|---|---|---|
|
Binocular Visual Acuity (VA) With Study Lenses at 4 Meters (logMAR)
|
-0.08 logMAR
Standard Deviation 0.06
|
-0.06 logMAR
Standard Deviation 0.06
|
Adverse Events
Pretreatment
LID#224381 Ocular
LID#224381 Nonocular
AOHG MF Ocular
AOHG MF Nonocular
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Sr. Clinical Project Lead, Vision Care
Alcon Research, LLC
Results disclosure agreements
- Principal investigator is a sponsor employee Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
- Publication restrictions are in place
Restriction type: OTHER